Multiplication of measles virus in the presence of actinomycin D, aurantin or 5-bromodeoxyuridine.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000378:metabolism* / Q000494:pharmacology*; D003470:Culture Media; D004247:DNA / Q000378:metabolism; D004279:DNA, Viral / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology*; D005419:Flavonoids / Q000494:pharmacology; D006384:Hemagglutination; D008459:Measles virus / Q000187:drug effects* / Q000254:growth & development; D012367:RNA, Viral / Q000096:biosynthesis; D014764:Viral Proteins / Q000096:biosynthesis; D014774:Virulence
D000903:Antibiotics, Antineoplastic; D003470:Culture Media; D004279:DNA, Viral; D005419:Flavonoids; D012367:RNA, Viral; D014764:Viral Proteins; D003609:Dactinomycin; D004247:DNA; D001973:Bromodeoxyuridine